NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

An Observational Study on RoActemra/Actemra (Tocilizumab) in Clinical Practice in Patients With Rheumatoid Arthritis (TRUST)

NCT01394276

CompletedN/A

Sponsor: Hoffmann-La Roche

Conditions: Rheumatoid Arthritis

Countries: Italy

This observational study will evaluate the efficacy and safety of RoActemra/Actemra (tocilizumab) in clinical practice in patients with moderate to severe rheumatoid arthritis. Data will be collected from patients for the 12 months following the first infusion of RoActemra/Actemra.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Adult patients, \>/= 18 years of age
* Rheumatoid arthritis diagnosed according to American College of Rheumatology (ACR) criteria
* Initiated on RoActemra/Actemra treatment according to the Summary of Product Characteristics not more than 6 months before opening of study center

Exclusion Criteria:

* Current serious infection
* Hypersensitivity to the active component or any of the excipients
* Pregnant women

Locations (56)

Coppito, Abruzzo, Italy
Pescara, Abruzzo, Italy
Brindisi, Apulia, Italy
Casarano (LE), Apulia, Italy
Foggia, Apulia, Italy
Martina Franca, Apulia, Italy
San Cesario di Lecce, Apulia, Italy
Reggio Calabria, Calabria, Italy
Avellino, Campania, Italy
Gragnano, Campania, Italy
Naples, Campania, Italy
Naples, Campania, Italy
Naples, Campania, Italy
Salerno, Campania, Italy
Telese Terme, Campania, Italy
Bologna, Emilia-Romagna, Italy
Ferrara, Emilia-Romagna, Italy
Modena, Emilia-Romagna, Italy
Piacenza, Emilia-Romagna, Italy
Trieste, Friuli Venezia Giulia, Italy
Albano Laziale, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Rome, Lazio, Italy
Viterbo, Lazio, Italy
Arenzano, Liguria, Italy
Castel Goffredo, Lombardy, Italy
Gavardo, Lombardy, Italy
+ 26 more on CT.gov